PTEN modulated trastuzumab sensitivity in HER2-overexpressing breast cancer, because of its opposition to phosphoinositide 3-kinase (PI3K) downstream signaling.12 Based on the correlation of high Fib status and trastuzumab treatment failure as shown above, we further evaluated the relationship between Fib status and PTEN. Here, ERBB2 is linked to breast cancer.